Skip to main content

Correction: Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6 - methyladenosine of Notch1

The Original Article was published on 25 November 2019

Correction: Mol Cancer 18, 168 (2019)

https://doi.org/10.1186/s12943-019-1084-1

Following the publication of the original paper [1], we have found several inadvertent errors in the figures recently. Those errors are as following:

The images for sphere formation assays in Fig. 6G (WT/shCtrl group), and dot blot assays in Fig. 2B and E were misused. After a self-investigation and carefully check of the archived images and raw data of this study, we found these errors happened inadvertently due to these images from different groups or different times were saved in a corresponded folder during the stage of saving the images. Besides, there is a mistake in Fig. 6D (WT and Mettl14 KO group). We incorrectly marked the superfluous time point “1.5 h” on top of “Notch1” northern blot images due to our carelessness. The corrected version of Fig. 6G&D and Fig. 2B&E have been provided. We sincerely apologize to the editor, reviewers and readers for the errors and any confusion it may have caused.

Fig. 2
figure 1

M6A modification was reduced in bladder TICs. A Bladder TICs and non-TICs were sorted by FACS with CD44 antibody, and mRNA was extracted for m6A detection. Six bladder tumors were used for TIC enrichment and subsequent m6A detection. B m6A RNA dot blot in bladder TICs and non-TICs. RNA extracted from bladder TICs and non-TICs was examined for m6A modification. Six samples were examined and got similar results. C FACS enriched TICs and non-TICs were stained with m6A and CD44 antibodies, and visualized by confocal microscopy. D Sphere formation was performed, followed by m6A detection using spheres and non-spheres. E Spheres and non-spheres were generated from bladder primary cells and m6A modification was detected. F, G Oncospheres and non-spheres were enriched from bladder cancer sample (F) or T24 cell line (G), followed by immunofluorescence detection of m6A modification. DIC, differential interference contrast. Six samples were examined and similar results were obtained, and sample #1 results were shown. *P < 0.05, **P < 0.01, ***P < 0.001, by two-tailed T test. At least threeindependent experiments were performed and got similar results

Fig. 6
figure 2

Mettl14 and m6A modification inhibited the stability of Notch1. A The related genes of Wnt/β-catenin, Notch and Hedeghog signaling were analyzed in Mettl14 knockout cells and Mettl14 overexpressing cells, and the expression was shown as heatmap. B, C Notch1 expression levels in Mettl14 knockout cells (B) and Mettl14 overexpressing cells (C) were examined by Western blot. Gapdh served as a loading control. D Mettl14 knockout cells were treated with 2 μg/mL actinomycin D, and then Notch1 mRNA levels at the indicated time points were examined by Northern blot. Actb was a loading control. E Correlation of Notch1 and Mettl14 expression. The expression levels of Notch1 and Mettl14 were used for analysis. Pearson correlation coefficient (R) and P-value were calculated. F Notch1 knockout cells were generated through CRISPR/Cas9 approach and examined by Western blot. G, H Sphere formation of Notch1 knockout cells. For G, typical images were shown in upper panels and calculated numbers were shown in lower panels. For H, spheres were detected for m6A levels, confirming the decreased m6A levels upon Mettl14 knockdown. I, J Sphere formation of Notch1 knockout cells. For I, typical images were shown in left panels and calculated numbers were shown in right panels. For J, invasive cells weredetected for m6A levels, confirming the decreased m6A levels upon Mettl14 knockdown. K Mettl14 was silenced in Notch1 knockout T24 cells, followed by sphere formation assay. ***P < 0.001; ns, not significant, by two-tailed T test. At least three independent experiments were performed and got similar results

Reference

  1. Gu C, Wang Z, Zhou N, Li G, Kou Y, Luo Y, et al. Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1. Mol Cancer. 2019;18:168.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jinjian Yang or Fengyan Tian.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gu, C., Wang, Z., Zhou, N. et al. Correction: Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6 - methyladenosine of Notch1. Mol Cancer 22, 9 (2023). https://doi.org/10.1186/s12943-023-01717-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12943-023-01717-x